HIV Clinical Trial
Official title:
Shang Ring Versus Forceps-guided Adult Male Circumcision: a Randomized Controlled Effectiveness Study in Southwestern Uganda.
Adult male circumcision (AMC) can reduce the incidence of HIV transmission by 40-60% in sub-Saharan Africa (SSA). The World Health Organisation and Joint United Nations Programme on HIV/AIDS advocate AMC for the reduction of HIV transmission in heterosexual men, and feasibility studies have demonstrated that AMC programmes can be effectively delivered to hyperendemic communities, such as those in SSA. Despite these recommendations, the potential effects of AMC have been attenuated by low uptake, with only 5% of all men who could benefit undergoing surgery to date. Traditional, time-consuming methods of AMC that require formal surgical training limit uptake in low-income countries. Training and implementation by non-physician health providers is dampened by a need to perform approximately 100 procedures to achieve satisfactory operative time and adverse effect rates. The investigators performed a randomised controlled effectiveness study to compare the shang ring (SR) with standard forceps-guided (FG)-AMC in a publicly funded regional referral hospital with a locally trained surgeon in Mbarara, western Uganda.
Male undergoing elective AMC were recruited from the surgical outpatient department of
Mbarara Regional Referral Hospital, Uganda. Patient age, marital status, smoking history and
motive to seek AMC were recorded for each participant.
The investigators performed block randomization by study day. Consenting participants
selected an opaque envelope from a box for randomization to SR or FG groups. All AMC
procedures were performed by a locally-trained surgeon who had performed over 100 prior FG
procedures but who had no prior experience of the SR procedure.
A study surgeon performed all procedures in the hospital operating theatres. In both study
groups, participants were cleaned with povidone iodine solution and draped in a sterile
fashion. Local anesthesia was administered to the dorsal penile nerve and penile ring blocks
using 3mg/kg of 1% lidocaine. The surgeon measured participants in the SR group to determine
ring size. Patients for whom a suitable ring size was not available crossed over to the FG
group, but remained in the SR group for intention to treat (ITT) analyses. An assistant
measured operative time using a stopwatch. For the SR group, timing began as the ring began
to be fitted, and ceased when the foreskin had been excised. For the FG group, timing began
at the first incision and ceased when the final suture was completed. Patients were
discharged on the day of procedure, provided with sterile gauze dressings, and informed to
change them twice daily until the first follow-up appointment.
All pre- and post-operative assessments were performed by the lead investigator at one hour
after the procedure, and on the 3rd, 7th, 14th and 21st post-operative days.
The investigators measured incidence rates of all outcomes and estimated relative risk for
the SR versus FG groups by fitting Poisson regression models with robust errors. The
investigators compared time to healing with Kaplan-Meier survival curves and measured for a
difference between groups using the likelihood ratio test. All analyses were initially
performed using ITT analysis, and were repeated with an as-treated analysis by reallocating
the 7 participants who crossed into the FG group.
;
Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06162897 -
Case Management Dyad
|
N/A | |
| Completed |
NCT03999411 -
Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients
|
Phase 4 | |
| Completed |
NCT02528773 -
Efficacy of ART to Interrupt HIV Transmission Networks
|
||
| Active, not recruiting |
NCT05454839 -
Preferences for Services in a Patient's First Six Months on Antiretroviral Therapy for HIV in South Africa
|
||
| Recruiting |
NCT05322629 -
Stepped Care to Optimize PrEP Effectiveness in Pregnant and Postpartum Women
|
N/A | |
| Completed |
NCT02579135 -
Reducing HIV Risk Among Adolescents: Evaluating Project HEART
|
N/A | |
| Active, not recruiting |
NCT01790373 -
Evaluating a Youth-Focused Economic Empowerment Approach to HIV Treatment Adherence
|
N/A | |
| Not yet recruiting |
NCT06044792 -
The Influence of Primary HIV-1 Drug Resistance Mutations on Immune Reconstruction in PLWH
|
||
| Completed |
NCT04039217 -
Antiretroviral Therapy (ART) Persistence in Different Body Compartments in HIV Negative MSM
|
Phase 4 | |
| Active, not recruiting |
NCT04519970 -
Clinical Opportunities and Management to Exploit Biktarvy as Asynchronous Connection Key (COMEBACK)
|
N/A | |
| Completed |
NCT04124536 -
Combination Partner HIV Testing Strategies for HIV-positive and HIV-negative Pregnant Women
|
N/A | |
| Recruiting |
NCT05599581 -
Tu'Washindi RCT: Adolescent Girls in Kenya Taking Control of Their Health
|
N/A | |
| Active, not recruiting |
NCT04588883 -
Strengthening Families Living With HIV in Kenya
|
N/A | |
| Completed |
NCT02758093 -
Speed of Processing Training in Adults With HIV
|
N/A | |
| Completed |
NCT02500446 -
Dolutegravir Impact on Residual Replication
|
Phase 4 | |
| Completed |
NCT03805451 -
Life Steps for PrEP for Youth
|
N/A | |
| Active, not recruiting |
NCT03902431 -
Translating the ABCS Into HIV Care
|
N/A | |
| Completed |
NCT00729391 -
Women-Focused HIV Prevention in the Western Cape
|
Phase 2/Phase 3 | |
| Recruiting |
NCT05736588 -
Elimisha HPV (Human Papillomavirus)
|
N/A | |
| Recruiting |
NCT03589040 -
Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant
|
Phase 2 |